title: Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
authors.affiliation: Endocrinology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. tuttlem@mskcc.org
authors.forename: R Michael
authors.initials: RM
authors.lastname: Tuttle
authors.forename: Hernan
authors.initials: H
authors.lastname: Tala
authors.forename: Jatin
authors.initials: J
authors.lastname: Shah
authors.forename: Rebecca
authors.initials: R
authors.lastname: Leboeuf
authors.forename: Ronald
authors.initials: R
authors.lastname: Ghossein
authors.forename: Mithat
authors.initials: M
authors.lastname: Gonen
authors.forename: Matvey
authors.initials: M
authors.lastname: Brokhin
authors.forename: Gal
authors.initials: G
authors.lastname: Omry
authors.forename: James A
authors.initials: JA
authors.lastname: Fagin
authors.forename: Ashok
authors.initials: A
authors.lastname: Shaha
mesh_terms: D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009367:Neoplasm Staging; D012008:Recurrence; D012189:Retrospective Studies; D012307:Risk Factors; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000473:pathology* / Q000628:therapy; D013965:Thyroidectomy
chemical_list: D007457:Iodine Radioisotopes; D013954:Thyroglobulin